Bioavailable copper modulates oxidative phosphorylation and growth of tumors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 48, 2013, Pages 19507-19512

  Ishida, Seiko ^a   Andreux, Pénélope ^b   Poitry Yamate, Carole ^c   Auwerx, Johan ^b   Hanahan, Douglas ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^b Chemical Engineering and Biochemistry Section   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

Cancer metabolism; Mitochondria; Pancreatic neuroendocrine tumor; Tumor energetics; Warburg effect

Indexed keywords

ADENOSINE TRIPHOSPHATE; COPPER; CYTOCHROME C OXIDASE; DRINKING WATER; GLUCOSE; TETRATHIOMOLYBDATE AMMONIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIOAVAILABILITY; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL STIMULATION; CHELATION; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PANCREAS TUMOR; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR INVASION; WATER SUPPLY;

CANCER METABOLISM; MITOCHONDRIA; PANCREATIC NEUROENDOCRINE TUMOR; TUMOR ENERGETICS; WARBURG EFFECT;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOLOGICAL AVAILABILITY; BLOTTING, WESTERN; COPPER; DNA PRIMERS; DRINKING WATER; ENERGY METABOLISM; GLYCOLYSIS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; POSITRON-EMISSION TOMOGRAPHY; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATION; TUMOR MICROENVIRONMENT; WATER POLLUTANTS, CHEMICAL;

EID: 84888322308     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1318431110     Document Type: Article

References (47)

1. Kim BE, Nevitt T, Thiele DJ (2008) Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol 4(3): 176-185.
2. Adelstein SJ, Vallee BL (1961) Copper metabolism in man. N Engl J Med 265: 892-897.
3. Linder MC, Moor JR,Wright K (1981) Ceruloplasmin assays in diagnosis and treatment of human lung, breast, and gastrointestinal cancers. J Natl Cancer Inst 67(2): 263-275.
4. Pagliardi E, Giangrandi E (1960) Clinical significance of the blood copper in Hodgkin's disease. Acta Haematol 24: 201-212.
5. Brem SS, et al. (1990) Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. Am J Pathol 137(5): 1121-1142.
6. Cox C, et al. (2001) The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma. Laryngoscope 111(4 Pt 1): 696-701.
7. Yoshii J, et al. (2001) The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int J Cancer 94(6): 768-773.
8. Pan Q, et al. (2002) Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res 62(17): 4854-4859.
9. Ishida S, McCormick F, Smith-McCune K, Hanahan D (2010) Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell 17(6): 574-583.
10. Hanahan D (1985) Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315(6015): 115-122.
11. Folkman J, Watson K, Ingber D, Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339(6219): 58-61.
12. Brewer GJ, et al. (1991) Initial therapy of patients with Wilson's disease with tetrathiomolybdate. Arch Neurol 48(1): 42-47.
13. Turnlund JR (1998) Human whole-body copper metabolism. Am J Clin Nutr 67(5, Suppl):960S-964S.
14. Efrat S, et al. (1988) β-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 85(23): 9037-9041.
15. Miniowitz-Shemtov S, Teichner A, Sitry-Shevah D, Hershko A (2010) ATP is required for the release of the anaphase-promoting complex/cyclosome from inhibition by the mitotic checkpoint. Proc Natl Acad Sci USA 107(12): 5351-5356.
16. Hudson DF, Marshall KM, Earnshaw WC (2009) Condensin: Architect of mitotic chromosomes. Chromosome Res 17(2): 131-144.
17. Nasmyth K, Haering CH (2009) Cohesin: Its roles and mechanisms. Annu Rev Genet 43: 525-558.
18. Sweet S, Singh G (1995) Accumulation of human promyelocytic leukemic (HL-60) cells at two energetic cell cycle checkpoints. Cancer Res 55(22): 5164-5167.
19. Nair PM, Mason HS (1966) Reconstitution of cytochrome c oxidase from an apoenzyme and Cu (I). Biochem Biophys Res Commun 23(1): 12-17.
20. Paynter DI, Moir RJ, Underwood EJ (1979) Changes in activity of the Cu-Zn superoxide dismutase enzyme in tissues of the rat with changes in dietary copper.JNutr 109(9): 1570-1576.
21. Hardie DG, Ross FA, Hawley SA (2012) AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13(4): 251-262.
22. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324(5930): 1029-1033.
23. Basu S (2010) Personalized versus evidence-based medicine with PET-based imaging. Nat Rev Clin Oncol 7(11): 665-668.
24. Brem S, Tsanaclis AM, Zagzag D (1990) Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain. Neurosurgery 26(3): 391-396.
25. Pan Q, Bao LW, Merajver SD (2003) Tetrathiomolybdate inhibits angiogenesis andmetastasis through suppression of the NFkappaB signaling cascade. Mol Cancer Res 1(10): 701-706.
26. Huang TT, et al. (1997) Superoxide-mediated cytotoxicity in superoxide dismutasedeficient fetal fibroblasts. Arch Biochem Biophys 344(2): 424-432.
27. Chandel NS, et al. (1998) Mitochondrial reactive oxygen species trigger hypoxiainduced transcription. Proc Natl Acad Sci USA 95(20): 11715-11720.
28. Semenza GL (2010) Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med 2(3): 336-361.
29. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE (2009) Mitochondria and reactive oxygen species. Free Radic Biol Med 47(4): 333-343.
30. Warburg O, Posener K, Negelein E (1924) Über den stoffwechsel der carcinomzelle. Biochem Z 152: 309-344.
31. Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11(2): 85-95.
32. Weinhouse S (1956) On respiratory impairment in cancer cells. Science 124(3215): 267-269.
33. Zu XL, Guppy M (2004) Cancer metabolism: Facts, fantasy, and fiction. Biochem Biophys Res Commun 313(3): 459-465.
34. Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E (2007) Energy metabolism in tumor cells. FEBS J 274(6): 1393-1418.
35. Funes JM, et al. (2007) Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc Natl Acad Sci USA 104(15): 6223-6228.
36. Fogal V, et al. (2010) Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol 30(6): 1303-1318.
37. El-Mir MY, et al. (2000) Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275(1): 223-228.
38. Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its antidiabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348(Pt 3): 607-614.
39. Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330(7503): 1304-1305.
40. Kourelis TV, Siegel RD (2012) Metformin and cancer: New applications for an old drug. Med Oncol 29(2): 1314-1327.
41. Hirst J, King MS, Pryde KR (2008) The production of reactive oxygen species by complex I. Biochem Soc Trans 36(Pt 5): 976-980.
42. Kushnareva Y, Murphy AN, Andreyev A (2002) Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem J 368(Pt 2): 545-553.
43. Shackelford DB, et al. (2013) LKB1 inactivation dictates therapeutic response of nonsmall cell lung cancer to the metabolism drug phenformin. Cancer Cell 23(2): 143-158.
44. Arnold S (2012) The power of life - cytochrome c oxidase takes center stage in metabolic control, cell signalling and survival. Mitochondrion 12(1): 46-56.
45. Gerlach W (1935) Über den kupfergehalt menschlicher tumoren in beziehung zum kupfergehalt der leber. Z Krebsforsch 42: 290-294.
46. Farquharson MJ, et al. (2008) The distribution of trace elements Ca, Fe, Cu and Zn and the determination of copper oxidation state in breast tumour tissue using muSRXRF and muXANES. Phys Med Biol 53(11): 3023-3037.
47. Ishida S, Lee J, Thiele DJ, Herskowitz I (2002) Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci USA 99(22): 14298-14302.